Physician

Ahmad El Kouzi, M.D

According to 2025 Medicare claims, Ahmad Kouzi, M.D (NPI: 1861834152) practices neurology in the Chicago-Naperville-Schaumburg, IL market, with the plurality of this provider's patient population coming from Du Page, IL. This provider's primary affiliated billing organization is ENDEAVOR HEALTH MEDICAL GROUP (NPI: 1497701882; TIN: 363738206) and primary practice location at 60540-6508. Kouzi is affiliated with the IRCCO (ACO ID: A2619) and BEST CARE COLLABORATIVE, LLC (ACO ID: A4937), participating under the MSSP model.

Kouzi's data goes back to 2015 and runs through 2024. For example, in 2024, this provider had 297 traditional Medicare patients, billed 10,539 HCPCS/CPT codes, and received $97,492 in Medicare payments. The top billing code was 99223 (Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes). Part D data shows 608 prescription claims across 172 beneficiaries totaling $352,691 in drug costs, led by Rytary (Carbidopa/Levodopa). DME data shows 39 claims. Open Payments data shows 14 records totaling $80,632. You can download detailed data with all billing codes (2015-2024). For more recent data, please contact us.

Over the past 10 years, this provider's Medicare Part B carrier billing did not follow a clear longitudinal pattern. Concurrently, Part D prescription costs have risen steadily, from $1,197 to $352,691. For DME billing, this provider has fewer than 5 years of reported data, so a reliable trend cannot be assigned.

Part B Carrier Billing Trend

Medicare payment trend, with N of patients and claim lines in the table.

Year	Patients	Clm Lines	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	55	635	$9,583
2020	306	8,122	$88,911
2021	325	13,650	$126,302
2022	287	14,600	$118,318
2023	246	14,977	$118,248
2024	297	10,539	$97,492

Part D Events Trend

Drug cost trend, with N of patients and prescription claims in the table.

Year	Patients	Claims	Drug Cost
2015	N/R	19	$1,197
2016	24	83	$16,136
2017	N/R	31	$4,809
2018	N/R	N/R	N/R
2019	43	131	$29,465
2020	109	616	$136,109
2021	143	757	$233,301
2022	162	824	$251,133
2023	140	658	$121,163
2024	172	608	$352,691

DME Billing Trend

Medicare payment trend, with N of patients and DME claim records in the table.

Year	Patients	Claims	Payment
2015	N/R	N/R	N/R
2016	N/R	N/R	N/R
2017	N/R	N/R	N/R
2018	N/R	N/R	N/R
2019	N/R	N/R	N/R
2020	N/R	N/R	N/R
2021	N/R	N/R	N/R
2022	N/R	58	$112,669
2023	N/R	76	$183,509
2024	N/R	39	$82,255

* / # = suppressed by CMS; 0 = reported zero; N/R = not reported or blank.

Top 5 Part B carrier billing codes in 2024

By total payments.

Code	Description	Patients	Clm Lines	Total Payment
99223	Initial hospital care with moderate level of medical decision making, if using time, at least 75 minutes	72	72	$138
99215	Established patient office or other outpatient visit with high level of medical decision making, if using time, 40 minutes or more	58	62	$134
99233	Subsequent hospital care with moderate levelof medical decision making, if using time, at least 50 minutes	40	58	$93
99214	Established patient office or other outpatient visit with moderate level of decision making, if using time, 30 minutes or more	54	57	$70
J0585	Injection, onabotulinumtoxina, 1 unit	33	10,080	$5

Top 5 Part D drugs in 2024

By total drug costs.

Drug	Generic	Claims	Total Day Supply	Total Drug Cost
Rytary	Carbidopa/Levodopa	18	592	$21,065
Carbidopa-Levodopa	Carbidopa/Levodopa	216	11,899	$6,179
Lacosamide	Lacosamide	18	528	$3,792
Carbidopa-Levodopa Er	Carbidopa/Levodopa	38	2,012	$2,723
Rasagiline Mesylate	Rasagiline Mesylate	18	1,057	$2,210

Top 5 DME services in 2024

By Total Medicare Payment Amount.

HCPCS Code	HCPCS Description	Supplier Rental Indicator	Total Supplier Beneficiaries	Total Supplier Claims	Total Medicare Payment Amount
J7340	Carbidopa 5 mg/levodopa 20 mg enteral suspension, 100 ml	N	N/R	13	$65,789
A4222	Infusion supplies for external drug infusion pump, per cassette or bag (list drugs separately)	N	N/R	13	$15,340
A4221	Supplies for maintenance of non-insulin drug infusion catheter, per week (list drugs separately)	N	N/R	13	$1,126

Open Payments Summary in 2024

Category	Definition	Records	Total Reported Amount	Top Related Entity
General Payments	Reported payment or transfer-of-value amount.	9	$513	ABBVIE INC.
Research Payments	Reported research-related payment or transfer-of-value amount.	5	$80,119	Genentech, Inc.
Ownership / Investment Interests	Reported value of ownership or investment interests.	0	$0	N/R

Explore More Providers

FAQ

What Medicare data is available for Ahmad El Kouzi, M.D?

Tedicare shows public-source Medicare data for Ahmad El Kouzi, M.D (NPI 1861834152), including provider identity, specialty, market context, Medicare Part B activity, Part D prescribing, DME records, Open Payments where available, billing organization details, and ACO affiliation signals where available. Profile data covers 2015-2024, with current attribution based on 2025 claims where available.

Does Ahmad El Kouzi, M.D have ACO affiliation data?

Ahmad El Kouzi, M.D is shown with ACO affiliation data for IRCCO (MSSP, ACO ID A2619) and BEST CARE COLLABORATIVE, LLC (MSSP, ACO ID A4937).

What billing organization is linked to Ahmad El Kouzi, M.D?

Ahmad El Kouzi, M.D is linked to ENDEAVOR HEALTH MEDICAL GROUP (billing NPI 1497701882) in the available physician profile data.

Does Ahmad El Kouzi, M.D have Open Payments data?

Ahmad El Kouzi, M.D has 14 connected Open Payments records in the available 2024 summary data.

Can I download physician-level Medicare data from Tedicare?

Yes. Tedicare provides sample physician export data and paid custom physician data exports for research, planning, outreach, and market analysis. Exports can include physician profile fields, market and specialty context, billing organization details, ACO affiliation signals where available, and Medicare utilization data.